Genprex (GNPX) Earnings Date, Estimates & Call Transcripts $0.29 -0.02 (-5.81%) Closing price 03:58 PM EasternExtended Trading$0.29 0.00 (-0.34%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Genprex Earnings Summary Upcoming Earnings DateMay. 21Before Market OpensEstimatedConsensus EPS (Aug. 9) -$2.30 Actual EPS (Aug. 9) -$3.00 Missed By -$0.70 Genprex released Q2 2024 earnings on August 9, 2024, reporting an EPS of -$3.00, which missed the consensus estimate of -$2.30 by $0.70. With a trailing EPS of $0.00, Genprex's earnings are expected to grow next year, from ($5.70) to ($2.71) per share. Aug. 9 Earnings ResourcesAug. 9 Earnings ReportGNPX Upcoming EarningsGenprex's next earnings date is estimated for Wednesday, May 21, 2025, based on past reporting schedules. Get Genprex Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Genprex and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGNPX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Genprex Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.86-$0.86-$0.86Q2 20251-$0.74-$0.74-$0.74Q3 20251-$0.65-$0.65-$0.65Q4 20251-$0.59-$0.59-$0.59 Genprex Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/21/2025(Estimated)--------8/9/2024--$2.30-$3.00 -$0.70-$3.00--5/15/2024Q1 2024-$2.54-$3.69 -$1.15-$3.69--11/14/2023Q3 2023-$4.40-$5.20 -$0.80-$0.13--8/21/2023Q2 2023-$4.80-$6.00 -$1.20-$0.15--5/22/2023Q1 2023-$4.80-$7.60 -$2.80-$0.19-- Genprex Earnings - Frequently Asked Questions When is Genprex's earnings date? Genprex has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 21st, 2025 based off last year's report dates. Learn more on GNPX's earnings history. Did Genprex beat their earnings estimates last quarter? In the previous quarter, Genprex (NASDAQ:GNPX) missed the analysts' consensus estimate of ($2.30) by $0.70 with a reported earnings per share (EPS) of ($3.00). Learn more on analysts' earnings estimate vs. GNPX's actual earnings. How much profit does Genprex generate each year? Genprex (NASDAQ:GNPX) has a recorded net income of -$30.86 million. GNPX has generated $0.00 earnings per share over the last four quarters. What is Genprex's EPS forecast for next year? Genprex's earnings are expected to grow from ($5.70) per share to ($2.71) per share in the next year. More Earnings Resources from MarketBeat Related Companies Kezar Life Sciences Earnings Results Marinus Pharmaceuticals Earnings Results Coeptis Therapeutics Earnings Results MiNK Therapeutics Earnings Results Allakos Earnings Results Generation Bio Earnings Results ALX Oncology Earnings Results Tempest Therapeutics Earnings Results Clene Earnings Results BioAtla Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Palantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 This page (NASDAQ:GNPX) was last updated on 5/6/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredREVEALED: Elon’s Secret Master Plan “AGENDA X”REVEALED: Elon's Secret Master Plan "AGENDA X" For almost 30 years, Elon worked on his master plan in secre...Brownstone Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump's $500B plan is fueling these monthly dividendsSomething extraordinary happened just 24 hours after Trump returned to office... He signed a document that ...Investors Alley | SponsoredConfidential Economic AdvisoryI've hesitated for months to record this video. The very act of sharing these details makes me deeply uncom...InvestorPlace | SponsoredThe New ElonThe New Face of DOGE? There is now a new, powerful and controversial figure at the heart of the DOGE agenda...Altimetry | SponsoredOur #1 Defense Stock for MayWe've already lost 18 straight simulated war games against China. The good news is, the U.S. military has a...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genprex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genprex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GNPX Stock Free GNPX Stock Alerts